An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...
JOE SHAPIRO, INVESTIGATIONS, NPR: My name is Joe Shapiro. I'm a correspondent at NPR. I work on the Investigations unit, but I've had a long interest in disability issues. I've been writing about this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results